Allogeneic donor bone marrow cells recovery and infusion after allogeneic face transplantation from the same donor

Bone Marrow Transplantation

Volumn 41, Issue 12, 2008, Pages 1059-1061

  Hequet, O ^a   Bourgeot, J P ^a   Michallet, M ^a   Morelon, E ^a   Dubernard, J M ^a   Dubois, V ^b   Devauchelle, B ^c  

^a EDOUARD HERRIOT HOSPITAL   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c Department of Pediatrics   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HLA A2 ANTIGEN; HLA A3 ANTIGEN; HLA B44 ANTIGEN; HLA B8 ANTIGEN; HLA DR15 ANTIGEN; HLA DR3 ANTIGEN; HLA DR7 ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUROLEPTIC AGENT; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOTRANSPLANTATION; ARTICLE; BLOOD GROUP O; CADAVER DONOR; CASE REPORT; COLONY FORMING UNIT GM; DOG BITE; DONOR; DRUG MEGADOSE; FACE INJURY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SKIN BIOPSY;

ADULT; BONE MARROW TRANSPLANTATION; FACIAL TRANSPLANTATION; FEMALE; HUMANS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 47849114113     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.23     Document Type: Article

References (10)

1. Thaunat O, Badat L, El-Jaafari A, Kanitakis J, Dubernard JM, Morelon E. Composite tissue allograft extends a helping hand to transplant immunologists. Am J Transplant 2006; 10: 2238-2242.
2. Ciancio G, Miller J, Garcia-Morales RO, Carreno M, Burke III GW, Roth D et al. Six-year clinical effect of donor marrow infusions in renal transplantation patients. Transplantation 2001; 71: 827-835.
3. Devauchelle B, Badet L, Lengele B, Morelon E, Testelin S, Michallet M et al. First face allograft: Early report. Lancet 2006; 368 203-209.
4. Ciancio G, Burke GW, Garcia-Morales R, Suzart K, Rosen A, Ricordi C et al. Effect of fiving-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients. Transplantation 2002; 74: 488-496.
5. Kapelushnik J, Aker M, Pugatsch T, Samuel S, Slavin S. Bone marrow transplantation from a cadaveric donor. Bone Marrow Transplant 1998; 21: 857 858.
6. Rybka WB, Fontes PA, Rao AS, Winkelstein A, Ricordi C, Ball ED et al Hematopoietic progenitor cell content of vertebral body marrow used for combined solid organ and bone marrow transplantation. Transplantation 1995; 59: 871-874.
7. Machalinski B, Gontarewicz A, Ratajczak MZ. Morphological analysis of the bone marrow biopsies derived from heparinized cadaveric organ donors before and after disconnecting from the respirator. Ann Transplant 2001; 6: 48-52.
8. Stubner S, Grohmann R, Engel R, Bandelow B, Ludwig WD, Wagner G et al Blood dyscrasias induced by psychotropic drugs. Pharmacopsychiatry 2004; 37: S70-S78.
9. Fudaba Y, Spitzer TR, Schaffer J, Kawai T, Fehr T, Delmonico F et al Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant 2006; 6: 2121-2133.
10. Caillat-Zucman S, Legendre C, Suberbielle C, Bodemer C, Noel LH, Kreis H et al. Microchimerism frequency two to thirty years after cadaveric Kidney transplantation. Hum Immunol 1994; 41: 91-95.